Huho, Bernadette J <br/><br/>
Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.  [electronic resource] 

 -  Malaria journal  Apr 2012 
 - 118 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1475-2875 
<br/><br/><label>Standard No.: </label>10.1186/1475-2875-11-118  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Protozoan--analysis<br/>Antimalarials--administration & dosage<br/>Artemisinins--administration & dosage<br/>Artesunate<br/>Asymptomatic Diseases--epidemiology<br/>Child, Preschool<br/>Culicidae--parasitology<br/>Disease Vectors<br/>Drug Combinations<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Malaria, Falciparum--drug therapy<br/>Plasmodium falciparum--isolation & purification<br/>Pregnancy<br/>Prevalence<br/>Pyrimethamine--administration & dosage<br/>Sulfadoxine--administration & dosage<br/>Tanzania--epidemiology